RT Journal Article
SR Electronic
T1 COVID-19 Vaccine Perceptions in New York State’s Intellectual and Developmental Disabilities Community
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.19.21253425
DO 10.1101/2021.03.19.21253425
A1 Suzannah Iadarola
A1 Joanne F. Siegel
A1 Qi Gao
A1 Kathleen McGrath
A1 Karen A. Bonuck
YR 2021
UL http://medrxiv.org/content/early/2021/03/22/2021.03.19.21253425.abstract
AB Background People with intellectual and developmental disabilities (IDD) are at disproportionate risk for severe COVID-19 outcomes, particularly those living in congregate care settings. Yet, there is limited data on vaccine perceptions in the disability community.Objective To explore COVID-19 vaccine perceptions in individuals with IDD, their family members, and those who work with them, to inform a statewide vaccine information and messaging project.Methods A national survey, adapted for the IDD community, was distributed to a convenience sample of IDD organizations throughout New York State, in five languages. Constructs included vaccine intention, reasons for vaccine hesitancy, and trusted sources of vaccine information. Zip code data were used to map respondent location and vaccine preferences.Results Of n= 825 respondents, approximately 75% intended to or had received the vaccine, across roles (i.e., people with disabilities, family members, direct care workers) and racial/ethnic groups. Greater vaccine hesitancy was reported in younger individuals and those making decisions on behalf of a person with IDD. Concerns included side effects and the swiftness of vaccine development. Black and Hispanic participants had heightened concerns about being an “experiment” for the vaccine. Trusted sources of information included healthcare providers and family members. Respondents who intended/got the vaccine were distributed throughout the state.Conclusions Vaccine preferences in this New York State disability community sample align with national data. Identified concerns suggest the need for community education that addresses misperceptions. Age and race differences in perspectives highlight the need for tailored education, delivered by trusted messengers.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialstudy was deemed exempt by IRBs of both institutionsFunding StatementThis work was supported by the Administration on Intellectual and Developmental Disabilities, US Department of Health and Human Services grant 90DD0661 (UCEDD; 2019); and the New York State Developmental Disabilities Planning Council.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project was deemed exempt from human subjects review by the Office of Human Research Affairs at Einstein College of Medicine-Montefiore Medical Center and the Office for Human Subject Protection at the University of Rochester. Participants with intellectual and developmental disabilities are included in the sample. Though such individuals may constitute a vulnerable population, this project- per above- was deemed exempt from human subjects review and thus participants were not asked to sign consents. Participation was voluntary and no protected health information was collected. The manuscript does not include any identifying information, thus no consent was obtained re: consent to have the results of the research work publisehd.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon request